Source comparison
Stacking MOTS-C NAD+ — Comparison of Research Protocols
Mitochondrial Biogenesis Markers (% increase in citrate synthase activity) 18–22% at 12 weeks 12–16% at 12 weeks 30–34% at 12 weeks Stack produces genuinely synergistic effect. Not merely additive VO2 Max Improvement (%) 9–12% in recreationally active adults 6
This comparison does not assign a generated winner or score.
- Mitochondrial Biogenesis Markers (% increase in citrate synthase activity)
- 18–22% at 12 weeks
- 12–16% at 12 weeks
- 30–34% at 12 weeks
- Stack produces genuinely synergistic effect. Not merely additive
- VO2 Max Improvement (%)
- 9–12% in recreationally active adults
- 6–9% in recreationally active adults
- 17–21% in recreationally active adults
- Combination effect exceeds sum of individual effects, suggesting pathway convergence
- Lactate Clearance Rate (post-exercise recovery)
- 14–17% faster clearance
- 8–11% faster clearance
- 24–28% faster clearance
- NAD+ restoration amplifies MOTS-C signaling by fueling LDH and sirtuin activity
- Insulin Sensitivity (HOMA-IR reduction)
- 22–28% improvement
- 15–19% improvement
- 35–42% improvement
- Both compounds improve glucose metabolism through distinct mechanisms. AMPK vs sirtuin-mediated
- Dosing Complexity
- 2–3 injections weekly, fasted state preferred
- Daily oral dose, timing flexible
- Injection + oral dose with 30–60 min timing gap
- Stack requires tighter protocol adherence but delivers measurably superior outcomes
- Reported Adverse Events (GI distress, injection site reactions)
- <5% in clinical trials
- <8% (primarily GI-related with NMN doses >500mg)
- <10% combined
- Adverse event rate is not significantly higher for combination vs monotherapy